Inventor · disambiguated record
Tomas Fex
Also filed as: FEX TOMAS
14 granted patents·10 pending applications·441 citations·filing 1986–2024
93Inventor score
Top patents by PatentIndex Score
24 records- 0194US6593343B2Quinoline derivativesACTIVE BIOTECH AB·Filed 2002·Granted Jul 15, 2003·60 cites·15 claims
- 0294US6077851AQuinoline derivativesACTIVE BIOTECH AB·Filed 1999·Granted Jun 20, 2000·139 cites·40 claims
- 0392US6605616B1Quinoline derivativesACTIVE BIOTECH AB·Filed 2000·Granted Aug 12, 2003·40 cites·18 claims
- 0487US6133285AQuinoline derivativesACTIVE BIOTECH AB·Filed 1999·Granted Oct 17, 2000·62 cites·41 claims
- 0585US6121287AQuinoline derivativesACTIVE BIOTECH AB·Filed 1999·Granted Sep 19, 2000·68 cites·38 claims
- 0679US12441718B2Selective angiotensin II compoundsVICORE PHARMA AB·Filed 2024·Granted Oct 14, 2025·0 cites·3 claims
- 0773US6642249B2Immunomodulating compoundsACTIVE BIOTECH AB·Filed 2002·Granted Nov 4, 2003·8 cites·22 claims
- 0866US4778789APiperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chainLEO AB·Filed 1986·Granted Oct 18, 1988·14 cites·8 claims
- 0963US4937245ABisphenylalkylpiperazine derivatives, a method of their preparation and a pharmaceutical preparationFEX TOMAS·Filed 1988·Granted Jun 26, 1990·14 cites·16 claims
- 1063US4935419ANovel 1-piperazinecarboxamide derivativesBJOERK ANDERS K K·Filed 1988·Granted Jun 19, 1990·16 cites·12 claims
- 1162US6423220B1Chromatographic method and chromatographic columns thereforTRIKONEX AB·Filed 2000·Granted Jul 23, 2002·6 cites·13 claims
- 1262US2024262813A1New selective angiotensin ii compoundsVICORE PHARMA AB·Filed 2022·Application pending·0 cites
- 1362US2025066282A1Novel analogs of valproic acid and methods of medical treatment using the sameCERENO SCIENT AB·Filed 2022·Application pending·0 cites
- 1461US12435072B2CompoundsVICORE PHARMA AB·Filed 2020·Granted Oct 7, 2025·0 cites·18 claims
- 1560US5734071AProcess for separating lipophilic compoundsTRIKONEX AB·Filed 1994·Granted Mar 31, 1998·14 cites·23 claims
- 1657US2024174657A1Selective angiotensin ii receptor ligandsVICORE PHARMA AB·Filed 2022·Application pending·0 cites
- 1755US2024197685A1Selective angiotensin ii receptor ligandsVICORE PHARMA AB·Filed 2022·Application pending·0 cites
- 1855US2024182461A1Selective angiotensin ii receptor ligandsVICORE PHARMA AB·Filed 2022·Application pending·0 cites
- 1953US2023348444A1Novel compounds for use in the treatment of diseases associated with angiotensin iiVICORE PHARMA AB·Filed 2021·Application pending·0 cites
- 2051US2023114153A1Imidazolyl thiopehene sulfonyl carbamates for use in the treatment of diseases associated with angiotensin iiVICORE PHARMA AB·Filed 2021·Application pending·0 cites
- 2149US2018338964A13-(piperidin-4-yl)-isoxazol-3(oh)-ones for treatment of dermatologic disordersEMERITI PHARMA AB·Filed 2018·Application pending·0 cites
- 2243US2008293587A1Method of Screening a Biological Target for Weak Interactions Using Weak Affinity ChromatographyTRANSIENTIC INTERACTIONS AB·Filed 2006·Application pending·0 cites
- 2342US2017360766A13-(piperidin-4-yl)-isoxazol-3(oh)-ones for treatment of dermatologic disordersEMERITI PHARMA AB·Filed 2015·Application pending·0 cites
- 2421US8415378B2Isoxazol-3(2H)-one analogs as therapeutic agentsBOSTROEM JONAS·Filed 2010·Granted Apr 9, 2013·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Tomas Fex files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →